Senate Panel Plans Looser Rules On Pay-For-Delay
The U.S. Senate Judiciary Committee is considering creating provisions in proposed legislation to allow pharmaceutical companies to forge deals delaying the market debut of generic drugs, if those deals present "clear...To view the full article, register now.
Already a subscriber? Click here to view full article